*Corresponding author:Kechaou Ines, Department B of Internal Medicine, Charles Nicolle Hospital, Boulevard 9 April 1938. 1080. Tunis, Tunisia
Received: May 30, 2018; Published: June 11, 2018
To view the Full Article Peer-reviewed Article PDF
Background: The purpose of our work was to study the epidemiological, clinical features and risk factors of erysipelas in Internal Medicine. Methods: Retrospective study including 86 patients with erysipelas collected at our department of internal medicine between 2005 and 2016.Results: There were 44 men and 42 women. The average age of our patients was 57.77. Erysipelas mainly affected the lower limbs in 95.3% of cases. Fever was present in 47.67% of cases. General underlying conditions were dominated by diabetes (55.8%), obesity (37.2%) and overweight (31.4%). Loco-regional favoring factors were essentially represented by lymphedema (18.6%), venous insufficiency (12.8%) and arteritis of the lower limbs (12.8%). A local site of entry was identified in 83.7% of the cases. The average number of total favorable factors was 3.12. Laboratory findings revealed leukocytosis in 66.3% of cases and CRP elevation in 77.6% of the cases. Bacteriological investigations identified gram negative bacilli in 3 patients: on blood cultures (Klebsiella Pneumoniae) and samples from needle aspirate (Enterobacter Cloacae and Serratia Marcescens). Erysipelas was recurrent in 45.34% of cases. Risk factors for recurrence were mycosis and lymphedema.
Conclusion: Prevention of erysipelas is essentially based on the treatment of local and general factors. Clinicians must be aware to the possibility of other causative microorganisms like GNB in front of erysipelas.
Keywords: Erysipelas; Risk Factor; Microbiology; Gram Negative Bacilli; Recurrence